Is Beximco Pharmaceuticals Ltd halal to invest in?

As of July 2026, Beximco Pharmaceuticals Ltd BXPHARMA.DS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Beximco Pharmaceuticals Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Beximco Pharmaceuticals Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Beximco Pharmaceuticals Ltd?

Muslim investors may consider investing in Beximco Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Beximco Pharmaceuticals Ltd classified as HALAL?

Musaffa determines the Shariah status of Beximco Pharmaceuticals Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Beximco Pharmaceuticals Ltd updated?

The Shariah compliance status of Beximco Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Beximco Pharmaceuticals Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Beximco Pharmaceuticals Ltd?

You can check the latest Shariah compliance status of Beximco Pharmaceuticals Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Beximco Pharmaceuticals Ltd BXPHARMA.DS

BXPHARMA.DS Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Beximco Pharmaceuticals Ltd is classified as halal.

HALAL

Report Source: 2025 2nd Quarter Report

Beximco Pharmaceuticals Ltd. Stock Analysis BXPHARMA.DS

Germany Health Care Small Cap Report: Q2, 2025

Beximco Pharmaceuticals Ltd. engages in the business of manufacturing and marketing generic pharmaceuticals formulation products covering a wide range of therapeutic categories. The firm is engaged in manufacturing and marketing of generic pharmaceutical formulation products covering a range of therapeutic categories. The company offers products in different dosage forms, including Solid, Liquid, Cream and Ointment, Suppositories, Metered Dose Inhaler, Dry Powder Inhaler, Nasal Spray, Sterile, Lyophilized Injectable and Large Volume Intravenous Fluids. Besides formulation products, the Company also manufactures APIs and renders contract manufacturing services to other companies. Products of the Company are sold in domestic and international markets. The subsidiaries of the Company include Nuvista Pharma Limited (NPL), Synovia Pharma PLC (SPP), Beximco Pharma API Limited (BPAL).

Key Statistics of Beximco Pharmaceuticals Ltd (BXPHARMA.DS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Open

Volume

P/E Ratio (TTM)

52 Week Range

€146.20€156.00

Market Cap

270.82M

Avg. Volume

Dividend Yield

2.39%

Financial Metrics & Statements of Beximco Pharmaceuticals Ltd (BXPHARMA.DS)

Super Investors Invested in Beximco Pharmaceuticals Ltd (BXPHARMA.DS)

FAQ's for Beximco Pharmaceuticals Ltd (BXPHARMA.DS)

As of July 2026, Beximco Pharmaceuticals Ltd BXPHARMA.DS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Beximco Pharmaceuticals Ltd using these criteria to determine its compliance status.
Muslim investors may consider investing in Beximco Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Beximco Pharmaceuticals Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Beximco Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Beximco Pharmaceuticals Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.